Literature DB >> 17620001

Derivation of various NONMEM estimation methods.

Yaning Wang1.   

Abstract

Various estimation methods and the lack of a systematic derivation of the core objective function implemented in NONMEM for nonlinear mixed effect modeling has caused consistent confusion and inquiry among scientists who routinely use NONMEM for data analysis. This paper provides a detailed derivation of the objective functions for the most commonly used estimation methods in NONMEM, such as the Laplacian method, the first-order conditional estimation method (FOCE) with or without interaction, and the first-order method (FO). In addition, models with homogenous or heterogeneous residual error were used to demonstrate the relationship between the objective functions derived from two different types of approximation, namely Laplacian approximation of log-likelihood and linearized model approximation. The relationship between these estimation methods and those implemented in SAS and Splus is discussed.

Mesh:

Year:  2007        PMID: 17620001     DOI: 10.1007/s10928-007-9060-6

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  1 in total

1.  Modelling of individual pharmacokinetics for computer-aided drug dosage.

Authors:  L B Sheiner; B Rosenberg; K L Melmon
Journal:  Comput Biomed Res       Date:  1972-10
  1 in total
  41 in total

1.  Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.

Authors:  Elodie L Plan; Alan Maloney; France Mentré; Mats O Karlsson; Julie Bertrand
Journal:  AAPS J       Date:  2012-04-14       Impact factor: 4.009

2.  Preconditioning of Nonlinear Mixed Effects Models for Stabilisation of Variance-Covariance Matrix Computations.

Authors:  Yasunori Aoki; Rikard Nordgren; Andrew C Hooker
Journal:  AAPS J       Date:  2016-02-08       Impact factor: 4.009

3.  Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

Authors:  Jae Eun Ahn; Mats O Karlsson; Adrian Dunne; Thomas M Ludden
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-08-07       Impact factor: 2.745

4.  Simultaneous optimal experimental design on dose and sample times.

Authors:  Joakim Nyberg; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-03-25       Impact factor: 2.745

5.  Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters.

Authors:  Julie Bertrand; Emmanuelle Comets; France Mentre
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

6.  Simultaneous optimal experimental design for in vitro binding parameter estimation.

Authors:  C Steven Ernest; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-08-13       Impact factor: 2.745

7.  Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.

Authors:  Radojka M Savic; Mats O Karlsson
Journal:  AAPS J       Date:  2009-08-01       Impact factor: 4.009

8.  Performance in population models for count data, part I: maximum likelihood approximations.

Authors:  Elodie L Plan; Alan Maloney; Iñaki F Trocóniz; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-08-04       Impact factor: 2.745

9.  Performance in population models for count data, part II: a new SAEM algorithm.

Authors:  Radojka Savic; Marc Lavielle
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-08-13       Impact factor: 2.745

10.  Cross-validation for nonlinear mixed effects models.

Authors:  Emily Colby; Eric Bair
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-03-27       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.